MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products... Show more
MetLife, Inc. (MET) is one of the world's largest life insurance and financial services companies, and it has built a long-standing reputation as a reliable dividend payer. The company distributes a quarterly dividend of $0.5925 per share, which translates to an annualized payout of approximately $2.37 per share and a dividend yield of roughly 2.4%. Payments are made on a consistent quarterly schedule, with the most recent ex-dividend date falling on August 4, 2026 and the corresponding payment date on September 8, 2026.
MetLife is best characterized as a dividend growth stock rather than a high-yield stock. While its yield is modest compared with some income-focused names, it has risen steadily and predictably for more than a decade. For investors who prioritize consistency, gradual increases, and financial stability over outsized current income, MetLife's dividend profile is a strong fit.
MetLife's dividend history reflects a disciplined, shareholder-friendly approach. The company has increased its dividend for 13 consecutive years, a streak that began around 2013 following the company's restructuring and renewed focus on its core insurance businesses. Over the past five years, the dividend has grown at an average annual rate of approximately 4.3%.
Recent history illustrates this steady progression. The quarterly payout climbed from $0.48 per share in 2021 to $0.50 in 2022, $0.52 in 2023, $0.545 in 2024, $0.5675 in 2025, and $0.5925 by 2026. Rather than delivering dramatic, one-time hikes, MetLife has favored small, consistent annual increases—a strategy that signals management's confidence in the durability of its cash flows and its commitment to returning capital to shareholders over the long term.
MetLife's dividend appears comfortably sustainable. The company's payout ratio—the share of earnings distributed as dividends—sits near 45% on a trailing twelve-month basis, a level that leaves meaningful room to absorb earnings volatility while continuing to fund the dividend. More importantly, MetLife's dividend consumes only about 9% to 10% of its free cash flow, an exceptionally low figure that underscores the strength of the insurer's cash generation.
The company's balance sheet also provides support. With a debt-to-equity ratio of roughly 0.73 and solid interest coverage, MetLife maintains the financial flexibility typical of a highly rated, diversified life insurer. This combination of a moderate earnings payout, abundant free cash flow, and manageable leverage suggests the dividend is well protected and that future increases remain plausible even during periods of economic uncertainty.
Within the life and multi-line insurance sector, MetLife's dividend yield of roughly 2.4% is broadly in line with—or slightly below—the industry average, which frequently lands between 3% and 3.7% depending on the benchmark. This positions MetLife as an average-to-modest yield among its peers rather than a standout high-yield play.
For context, competitors such as Prudential Financial (PRU), Aflac (AFL), and Unum Group (UNM) operate in the same space, and yields across the group tend to cluster in a similar range. Where MetLife distinguishes itself is in the consistency and longevity of its payout growth. Its 13-year growth streak and low cash-flow payout ratio give it a defensive, income-compounding profile that some higher-yielding peers cannot match as reliably.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters covering industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can help identify dividend stocks, income-focused investments, trending names, breakout candidates, and market opportunities more efficiently than manual screening. For investors seeking to build a dividend-focused watchlist, the AI Screener offers a fast, data-driven way to surface potential candidates and compare them side by side.
MetLife is likely to appeal most to long-term, dividend-growth investors and conservative income seekers who value reliability over maximum yield. Its roughly 2.4% yield is not among the highest in the insurance sector, but its 13-year growth streak, low payout ratio, and abundant free cash flow make it an attractive candidate for investors who want a growing, well-covered income stream with lower dividend-cut risk.
The stock may be less compelling for investors who need substantial current income or who prioritize the highest available yield, since other insurers and sectors offer larger distributions. Similarly, investors focused on rapid capital appreciation may find MetLife's steady, compounding profile less exciting than faster-growing names. Overall, MetLife sits comfortably in the middle of the dividend-investing spectrum: a durable, moderately yielding payer best suited to patient investors building long-term income through consistent, incremental dividend growth.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of insurance and financial services and also function as bank holding company
Industry LifeHealthInsurance